Freedom of expression

SEC Awards $22 Million to Two Whistleblowers

Retrieved on: 
Monday, May 10, 2021

b'Washington, D.C.--(Newsfile Corp. - May 10, 2021) - The Securities and Exchange Commission today announced awards totaling approximately $22 million to two whistleblowers whose information and assistance were of crucial importance to successful SEC enforcement actions brought against a financial services firm.\nThe first whistleblower received an award of $18 million, while the second whistleblower received a $4 million award.

Key Points: 
  • b'Washington, D.C.--(Newsfile Corp. - May 10, 2021) - The Securities and Exchange Commission today announced awards totaling approximately $22 million to two whistleblowers whose information and assistance were of crucial importance to successful SEC enforcement actions brought against a financial services firm.\nThe first whistleblower received an award of $18 million, while the second whistleblower received a $4 million award.
  • \xe2\x80\x9cThe reporting of credible information by these whistleblowers and their subsequent cooperation with the staff\xe2\x80\x99s investigation allowed the Commission to better understand complex transactions related to the matters under investigation.\xe2\x80\x9d\nThe SEC has awarded approximately $838 million to 156 individuals since issuing its first award in 2012.
  • No money has been taken or withheld from harmed investors to pay whistleblower awards.
  • Whistleblowers may be eligible for an award when they voluntarily provide the SEC with original, timely, and credible information that leads to a successful enforcement action.

LOST MONEY IN PTON? HAGENS BERMAN, National Trial Attorneys, Alerts Peloton Interactive (PTON) Investors to Securities Fraud Class Action, Advises Investors to Contact the Firm Now

Retrieved on: 
Monday, May 10, 2021

17, 2021, when the U.S. Consumer Product Safety Commission urgently warned consumers to stop using the Tread+ after finding one death and dozens of incidents of children being sucked under the Tread+.

Key Points: 
  • 17, 2021, when the U.S. Consumer Product Safety Commission urgently warned consumers to stop using the Tread+ after finding one death and dozens of incidents of children being sucked under the Tread+.
  • Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC.
  • For more information, call Reed Kathrein at 844-916-0895 or email [email protected]\nHagens Berman is a national law firm with eight offices in eight cities around the country and over eighty attorneys.
  • The firm represents investors, whistleblowers, workers and consumers in complex litigation.

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Acadia Pharmaceuticals (ACAD) Investors to Securities Class Action, Advises Investors with Losses to Contact Its Attorneys Now

Retrieved on: 
Saturday, May 8, 2021

Thereafter, the company repeatedly stated the FDA had not identified any potential review issues and reiterated the drug\xe2\x80\x99s efficacy.\nBut the truth began to emerge on Mar.

Key Points: 
  • Thereafter, the company repeatedly stated the FDA had not identified any potential review issues and reiterated the drug\xe2\x80\x99s efficacy.\nBut the truth began to emerge on Mar.
  • 8, 2021, when Acadia announced that on Mar.
  • 3, 2021 the FDA informed the company that it had identified deficiencies in the sNDA.\nThen, on Apr.
  • Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC.

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Amdocs Limited (DOX) Investors to SECURITIES CLASS ACTION and Application Deadline: Investors Should Secure Counsel

Retrieved on: 
Saturday, May 8, 2021

Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC.

Key Points: 
  • Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC.
  • For more information, call Reed Kathrein at 844-916-0895 or email [email protected] .\nHagens Berman is a national law firm with eight offices in eight cities around the country and over eighty attorneys.
  • The firm represents investors, whistleblowers, workers and consumers in complex litigation.
  • For the latest news visit our newsroom or follow us on Twitter at @classactionlaw .\n'

Investor Alert: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against Canoo Inc. (GOEV)

Retrieved on: 
Friday, May 7, 2021

For additional information or to learn how to participate in this litigation please contact Kessler Topaz Meltzer & Check, LLP: James Maro, Esq.

Key Points: 
  • For additional information or to learn how to participate in this litigation please contact Kessler Topaz Meltzer & Check, LLP: James Maro, Esq.
  • Canoo also filed its Prospectus on a Form 424b3 with the SEC on December 4, 2020.
  • \xc2\xa0The firm represents investors, consumers and whistleblowers (private citizens who report fraudulent practices against the government and share in the recovery of government dollars).\xc2\xa0 The complaint in this action was not filed by Kessler Topaz Meltzer & Check, LLP.
  • For more information about Kessler Topaz Meltzer & Check, LLP please visit www.ktmc.com .\nKessler Topaz Meltzer & Check, LLP\n'

ATNX DEADLINE MONDAY: HAGENS BERMAN, National Trial Attorneys, Alerts Athenex (ATNX) Investors to May 3rd Application Deadline in Securities Class Action, Advises Investors with Losses to Contact the Firm Immediately

Retrieved on: 
Saturday, May 1, 2021

1, 2021, the market learned the truth when Athenex announced it received the FDA\xe2\x80\x99s complete response letter (\xe2\x80\x9cCRL\xe2\x80\x9d) to the NDA for oral paclitaxel plus encequidar.

Key Points: 
  • 1, 2021, the market learned the truth when Athenex announced it received the FDA\xe2\x80\x99s complete response letter (\xe2\x80\x9cCRL\xe2\x80\x9d) to the NDA for oral paclitaxel plus encequidar.
  • In the CRL, the FDA cited safety risks to patients in terms of an increase in neutropenia-related sequalae.
  • Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC.
  • The firm represents investors, whistleblowers, workers and consumers in complex litigation.\xc2\xa0\xc2\xa0 More about the firm and its successes is located at hbsslaw.com .

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Reminds Ebang International Holdings (EBON) Investors of Securities Class Action and Encourages Investors with Losses to Contact Its Attorneys

Retrieved on: 
Monday, April 26, 2021

b'SAN FRANCISCO, April 26, 2021 (GLOBE NEWSWIRE) -- Hagens Berman urges Ebang International Holdings (NASDAQ: EBON) investors with significant losses to submit your losses now .

Key Points: 
  • b'SAN FRANCISCO, April 26, 2021 (GLOBE NEWSWIRE) -- Hagens Berman urges Ebang International Holdings (NASDAQ: EBON) investors with significant losses to submit your losses now .
  • Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC.
  • The firm represents investors, whistleblowers, workers and consumers in complex litigation.
  • For the latest news visit our newsroom or follow us on Twitter at @classactionlaw .\n'

ATNX 2-WEEK DEADLINE ALERT: HAGENS BERMAN Urges Athenex (ATNX) Investors with Losses to Contact Its Attorneys, Securities Class Action Deadline Approaching

Retrieved on: 
Monday, April 19, 2021

1, 2021, the market learned the truth when Athenex announced it received the FDA\xe2\x80\x99s complete response letter (\xe2\x80\x9cCRL\xe2\x80\x9d) to the NDA for oral paclitaxel plus encequidar.

Key Points: 
  • 1, 2021, the market learned the truth when Athenex announced it received the FDA\xe2\x80\x99s complete response letter (\xe2\x80\x9cCRL\xe2\x80\x9d) to the NDA for oral paclitaxel plus encequidar.
  • In the CRL, the FDA cited safety risks to patients in terms of an increase in neutropenia-related sequalae.
  • Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC.
  • The firm represents investors, whistleblowers, workers and consumers in complex litigation.\xc2\xa0\xc2\xa0 More about the firm and its successes is located at hbsslaw.com .

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Franklin Wireless Corp. (FKWL) on Behalf of Investors

Retrieved on: 
Friday, April 9, 2021

Glancy Prongay & Murray LLP (GPM), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Franklin Wireless Corp. (Franklin or the Company) (NASDAQ: FKWL ) investors concerning the Companys possible violations of the federal securities laws.

Key Points: 
  • Glancy Prongay & Murray LLP (GPM), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Franklin Wireless Corp. (Franklin or the Company) (NASDAQ: FKWL ) investors concerning the Companys possible violations of the federal securities laws.
  • On this news, the Companys share price fell as much as 22% during intraday trading on April 9, 2021.
  • Whistleblower Notice: Persons with non-public information regarding Franklin should consider their options to aid the investigation or take advantage of the SEC Whistleblower Program.
  • Glancy Prongay & Murray LLP is a premier law firm representing investors and consumers in securities litigation and other complex class action litigation.

SEC Awards Approximately $2.5 Million to Whistleblower

Retrieved on: 
Friday, April 9, 2021

Washington, D.C.--(Newsfile Corp. - April 9, 2021) - The Securities and Exchange Commission today announced an award of approximately $2.5 million to a whistleblower whose information and ongoing assistance to the staff significantly contributed to the success of an SEC enforcement action.

Key Points: 
  • Washington, D.C.--(Newsfile Corp. - April 9, 2021) - The Securities and Exchange Commission today announced an award of approximately $2.5 million to a whistleblower whose information and ongoing assistance to the staff significantly contributed to the success of an SEC enforcement action.
  • The SEC has awarded approximately $762 million to 148 individuals since issuing its first award in 2012.
  • No money has been taken or withheld from harmed investors to pay whistleblower awards.
  • Whistleblower awards can range from 10 percent to 30 percent of the money collected when the monetary sanctions exceed $1 million.